Oncolytic virotherapy

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
Erica B Flores, Bulent A Aksoy, Eric Bartee

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000804; DOI: 10.1136/jitc-2020-000804
Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy
Mee Y. Bartee, Parker C. Dryja, Eric Bartee

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 11; DOI: 10.1186/s40425-018-0496-6
Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
Dong Ho Shin, Teresa Nguyen, Bulent Ozpolat, Frederick Lang, Marta Alonso, Candelaria Gomez-Manzano, Juan Fueyo

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002086; DOI: 10.1136/jitc-2020-002086
Oncolytic herpesvirus expressing PD-L1 BiTE for cancer therapy: exploiting tumor immune suppression as an opportunity for targeted immunotherapy
Hena Khalique, Richard Baugh, Arthur Dyer, Eleanor M. Scott, Sally Frost, Sarah Larkin, Janet Lei-Rossmann, Leonard W. Seymour

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (4) e001292; DOI: 10.1136/jitc-2020-001292
Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma
Georgia M Beasley, Smita K Nair, Norma E Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs, Sin-Ho Jung, Darell D Bigner, Andrea True Kelly, Matthias Gromeier, April KS Salama

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002203; DOI: 10.1136/jitc-2020-002203
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer
Yu Seong Lee, Won Suk Lee, Chang Woo Kim, Seung Joon Lee, Hannah Yang, So Jung Kong, John Ning, Kyung-Mee Yang, Beodeul Kang, Woo Ram Kim, Hong Jae Chon, Chan Kim

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e000857; DOI: 10.1136/jitc-2020-000857
Clinical landscape of oncolytic virus research in 2020
Nicholas Macedo, David M Miller, Rizwan Haq, Howard L Kaufman

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001486; DOI: 10.1136/jitc-2020-001486
Relaxin-expressing oncolytic adenovirus induces remodeling of physical and immunological aspects of cold tumor to potentiate PD-1 blockade
Bo-Kyeong Jung, Hae Young Ko, Hyunji Kang, JinWoo Hong, Hyo Min Ahn, Youjin Na, Hyeongi Kim, Jin Su Kim, Chae-Ok Yun

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e000763; DOI: 10.1136/jitc-2020-000763

Main menu

Oncolytic virotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Oncolytic virotherapy

Pages